Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 04 September 2018

Indication(s)

Pergoveris is indicated for the stimulation of follicular development in adult women with severe LH and FSH deficiency.
In clinical trials, these patients were defined by an endogenous serum LH level < 1.2 IU/l.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Cardiovascular Metabolism Knowledge Centre

Cardiovascular Metabolism Knowledge Centre

The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/000714
Orphan designation No
Date First Approved 25-06-2007
Type Medicinal product subject to restricted medical prescription
Marketing authorisation holder Merck Europe B.V.